Search Results - "Bode, AM"
-
1
The Two Faces of Capsaicin
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is the principal pungent component in hot peppers, including red chili peppers, jalapeños, and habaneros…”
Get full text
Journal Article -
2
Post-translational modification of p53 in tumorigenesis
Published in Nature reviews. Cancer (01-10-2004)“…Interest in the tumour suppressor p53 has generated much information regarding the complexity of its function and regulation in carcinogenesis. However, gaps…”
Get full text
Journal Article -
3
Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells
Published in Leukemia (01-06-2017)“…Obesity is becoming more prevalent worldwide and is a major risk factor for cancer development. Acute myeloid leukemia (AML), the most common acute leukemia in…”
Get full text
Journal Article -
4
A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target
Published in Leukemia (01-04-2018)“…Aberrant DNA methylation mediated by deregulation of DNA methyltransferases (DNMT) is a key hallmark of acute myeloid leukemia (AML), yet efforts to target…”
Get full text
Journal Article -
5
Targeting PRPK and TOPK for skin cancer prevention and therapy
Published in Oncogene (01-10-2018)“…Solar ultraviolet (sUV) irradiation is a major environmental carcinogen that can cause inflammation and skin cancer. The costs and morbidity associated with…”
Get full text
Journal Article -
6
Targeting signal transduction pathways by chemopreventive agents
Published in Mutation research (02-11-2004)“…Cancer is a dynamic process that involves many complex factors, which may explain why a "magic bullet" cure for cancer has not been found. Death rates are…”
Get more information
Journal Article -
7
Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1
Published in Oncogene (14-05-2015)“…Resveratrol ( trans -3,5,4′-truhydroxystilbene) possesses a strong anticancer activity exhibited as the induction of apoptosis through p53 activation. However,…”
Get full text
Journal Article -
8
Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis
Published in Cancer research (Chicago, Ill.) (01-02-2009)“…Blockade of the transient receptor potential channel vanilloid subfamily 1 (TRPV1) is suggested as a therapeutic approach to pain relief. However, TRPV1 is a…”
Get full text
Journal Article -
9
The Intermediate Filament Protein Vimentin Is a New Target for Epigallocatechin Gallate
Published in The Journal of biological chemistry (29-04-2005)“…Epigallocatechin gallate (EGCG) is the major active polyphenol in green tea. Protein interaction with EGCG is a critical step in the effects of EGCG on the…”
Get full text
Journal Article -
10
The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects
Published in Critical reviews in oncology/hematology (01-04-2002)“…Arsenic is a well-documented carcinogen that also appears to be a valuable therapeutic tool in cancer treatment. This creates a paradox for which no unified…”
Get full text
Journal Article -
11
Abstract P1-08-03: Identification and characterization of a novel endoxifen substrate, PKCβ1, and its interaction with the estrogen receptor
Published in Cancer research (Chicago, Ill.) (15-02-2017)“…Abstract Background: The primary mechanism by which tamoxifen (Tam) and its metabolites exert their biologic effects is through estrogen receptor (ER) binding…”
Get full text
Journal Article -
12
Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase
Published in Cancer research (Chicago, Ill.) (15-02-2001)“…Resveratrol, a phytoalexin found in grapes, berries, and peanuts, is one of the most promising agents for cancer prevention. Our previous study showed that the…”
Get full text
Journal Article -
13
P3-11-07: Mammary Gland Biopsy To Examine Surrogate Endpoint Biomarkers of Preventive Agent Efficacy
Published in Cancer research (Chicago, Ill.) (15-12-2011)“…Abstract Phase II breast cancer prevention trials examine agent activity by sampling and imaging the breast through core needle biopsy, fine needle aspiration,…”
Get full text
Journal Article -
14
P3-10-01: Alternative Dosing Regimens with the EGFr Inhibitors (Gefitinib and Lapatinib) in Mammary Cancer Models: Prevention and Therapeutic Efficacy
Published in Cancer research (Chicago, Ill.) (15-12-2011)“…Abstract The EGFR inhibitors are effective in treatment of lung and pancreatic cancers (erlotinib, gefitinib) and Neu overexpressing breast cancer (lapatinib)…”
Get full text
Journal Article -
15
Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways
Published in Cancer research (Chicago, Ill.) (01-08-2003)“…Caffeine is a key component of many popular drinks, especially tea and coffee. Previous reports have shown that caffeine may contribute to the chemopreventive…”
Get full text
Journal Article -
16
P5-06-11: Quercetin-3-Methyl Ether Inhibits Lapatinib-Sensitive and Lapatinib-Resistant Breast Cancer Cell Growth by Inducing G2/M Arrest and Apoptosis
Published in Cancer research (Chicago, Ill.) (15-12-2011)“…Abstract Background: Lapatinib, an oral, small-molecule, reversible inhibitor of both EGFR and HER2, is highly active in HER2 positive breast cancer as a…”
Get full text
Journal Article -
17
Abstract P5-09-08: A comparison of the non-genomic effects of endoxifen and tamoxifen in aromatase inhibitor resistant breast cancer: Differential effects on the estrogen receptor co-regulator SRC3 (AIB1) and identification of PKC and PI3K as endoxifen substrates
Published in Cancer research (Chicago, Ill.) (15-12-2013)“…Abstract Background: Endoxifen (Endx) is being developed as a drug for patients with estrogen receptor (ER)+ breast cancer (BC). We previously demonstrated…”
Get full text
Journal Article -
18
Abstract PD03-07: Evaluation of the Anti-Diabetic Drug Metformin in the Methylnitrosourea (MNU)-Induced Model of ER+ Mammary Cancer and the MMTV-Neu/p53KO Model of ER-Mammary Cancer
Published in Cancer research (Chicago, Ill.) (15-12-2010)“…Abstract Metformin, an anti-diabetic drug, activates AMP-activated protein kinase (AMPK), and has generated a great deal of interest as a potential preventive…”
Get full text
Journal Article -
19
Deficiency of c-Jun-NH2-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate
Published in Cancer research (Chicago, Ill.) (01-03-2002)Get full text
Journal Article -
20
Suppression of skin tumorigenesis in c-Jun NH2-terminal kinase-2-deficient mice
Published in Cancer research (Chicago, Ill.) (15-05-2001)Get full text
Journal Article